SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emami reply to clarification sought by the exchange

22 May 2015 Evaluate

The Exchange had sought clarification from Emami with respect to media flash on ET now @ 13:50 titled ‘Emami is in advanced talks to buy Kesh King brand from Himachal Pradesh based SBS Biotech. Deal to be valued around Rs 1800 crs’. Emami replied stating that the aforesaid news item has appeared on ET NOW without our knowledge and concurrence. Further there has not been any event which requires intimation to the Stock Exchange under Clause 36 of the Listing Agreement.

The above information is a part of company’s filings submitted to BSE.

Emami Share Price

451.45 25.50 (5.99%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2241.10
Godrej Consumer Prod 1108.20
Dabur India 442.10
Colgate Palmol. (I) 2106.20
P&G Hygiene 10006.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×